The effect of Glucagon-like-Peptide-1 receptor agonists on diabetic retinopathy progression, central subfield thickness, and response to intravitreal injections
doi:10.1016/j.ejphar.2020.173494 124 Liu, Y
Semaglutide, the active ingredient in injectable GLP-1 therapies, follows a specific elimination pattern in your body that affects how long you'll experience its weight-loss and appetite-suppressing effects
G., Gannon, J., & Rich, P
Because simple sugar is the fastest, most easily accessible form of energy for your cells, your brain begins generating vivid thoughts of sweets